Treatment of type 2 diabetes mellitus in elderly patients

被引：28
|
作者：
Gomez-Huelgas, R. [1 ,2 ,3 ,4 ]
Gomez Peralta, F. [5 ,6 ]
Rodriguez Manas, L. [7 ,8 ,9 ]
Formiga, F. [10 ,11 ]
Puig Domingo, M. [12 ,13 ,14 ,15 ]
Mediavilla Bravo, J. J. [16 ,17 ]
Miranda, C. [18 ,19 ]
Ena, J. [4 ,20 ]
机构：
[1] Univ Malaga, Hosp Reg, Serv Med Interna, Malaga, Spain
[2] Inst Invest Biomed Malaga IBIMA, Malaga, Spain
[3] Inst Salud Carlos III, CIBER Obesidad & Nutr CIBEROBN, Madrid, Spain
[4] SEMI, Madrid, Spain
[5] Hosp Gen Segovia, Unidad Endocrinol & Nutr, Segovia, Spain
[6] SED, Madrid, Spain
[7] Hosp Univ Getafe, Serv Geriatria, Madrid, Spain
[8] Inst Salud Carlos III, CIBER Fragilidad & Envejecimiento Saludable CIBER, Madrid, Spain
[9] Soc Espanola Med Geriatr SEMEG, Madrid, Spain
[10] Hosp Univ Bellvitge, Unidad Geriatria, Barcelona, Spain
[11] SEGG, Madrid, Spain
[12] Hosp Badalona Germans Trias & Pujol, Serv Endocrinol & Nutr, Barcelona, Spain
[13] Inst Invest Ciencies Salut Germans Trias & Pujol, Barcelona, Spain
[14] Inst Salud Carlos III, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Madrid, Spain
[15] SEEN, Madrid, Spain
[16] Ctr Salud Burgos Rural, Burgos, Spain
[17] Soc Espanola Med Gen SEMERGEN, Madrid, Spain
[18] Ctr Salud Buenavista, Toledo, Spain
[19] Soc Espanola Med Gen &Familia SEMG, Madrid, Spain
[20] Hosp Marina Baixa, Serv Med Interna, Alicante, Spain
来源：
REVISTA CLINICA ESPANOLA | 2018年 / 218卷 / 02期
关键词：
Type 2 diabetes mellitus; Elderly; Antidiabetic treatment; RANDOMIZED CLINICAL-TRIAL; BIPHASIC INSULIN ASPART; ONCE-WEEKLY DULAGLUTIDE; CHRONIC KIDNEY-DISEASE; FRAIL OLDER-ADULTS; DOUBLE-BLIND; GLYCEMIC CONTROL; CARDIOVASCULAR OUTCOMES; POOLED ANALYSIS; OPEN-LABEL;
D O I：
10.1016/j.rce.2017.12.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The prevalence of type 2 diabetes mellitus (DM2) increases markedly with age. Anti diabetic treatment and the objectives of glycaemic control in elderly patients with DM2 should be individualised according to their biopsychosocial characteristics. In elderly patients for whom the benefits of intensive antidiabetic treatment are limited, the basic objectives should be to improve the quality of life, preserve functionality and avoid adverse effects, especially hypoglycaemia. Treatment of DM2 in the elderly was the subject of a consensus document published in 2012 and endorsed by several Spanish scientific societies. Since then, new therapeutic groups and evidence have emerged that warrant an update to this consensus document. The present document focuses on the therapeutic aspects of DM2 in elderly patients, understood as being older than 75 years or frail. (C) 2017 Elsevier Espana, S.L.U. and Sociedad Espanola de Medicina Interna (SEMI). All rights reserved.
引用
收藏
页码：74 / 88
页数：15
相关论文
共 50 条
  • [31] Acarbose in the treatment of elderly patients with type 2 diabetes
    Josse, RG
    Chiasson, JL
    Ryan, EA
    Lau, DCW
    Ross, SA
    Yale, JF
    Leiter, LA
    Maheux, P
    Tessier, D
    Wolever, TMS
    Gerstein, H
    Rodger, NW
    Dornan, JM
    Murphy, LJ
    Rabasa-Lhoret, R
    Meneilly, GS
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 59 (01) : 37 - 42
  • [32] Role of vildagliptin in managing type 2 diabetes mellitus in the elderly
    Halimi, S.
    Raccah, D.
    Schweizer, A.
    Dejager, S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (07) : 1647 - 1656
  • [33] Effect of statin treatment on mortality in elderly patients with type 2 diabetes mellitus patients: a retrospective cohort study
    Yao Fan
    Juan Wang
    Haidi Wu
    Lingli Dai
    Lan Wang
    Liubao Gu
    BMC Geriatrics, 23
  • [34] Diabetes Knowledge in Elderly Type 2 Diabetes Mellitus Patients and Association with Glycemic Control
    Shams, Nadia
    Amjad, Sadia
    Seetlani, Naresh Kumar
    Ahmed, Waqar
    JOURNAL OF THE LIAQUAT UNIVERSITY OF MEDICAL AND HEALTH SCIENCES, 2016, 15 (02): : 71 - 77
  • [35] Monotherapy in Patients with Type 2 Diabetes Mellitus
    Rhee, Sang Youl
    Kim, Hyun Jin
    Ko, Seung-Hyun
    Hur, Kyu-Yeon
    Kim, Nan-Hee
    Moon, Min Kyong
    Park, Seok-O
    Lee, Byung-Wan
    Choi, Kyung Mook
    Kim, Jin Hwa
    DIABETES & METABOLISM JOURNAL, 2017, 41 (05) : 349 - 356
  • [36] Monotherapy in patients with type 2 diabetes mellitus
    Rhee, Sang Youl
    Kim, Hyun Jin
    Ko, Seung-Hyun
    Hur, Kyu Yeon
    Kim, Nan-Hee
    Moon, Min Kyong
    Park, Seok-O
    Lee, Byung-Wan
    Choi, Kyung Mook
    Kim, Jin Hwa
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (06) : 959 - 966
  • [37] Consensus on the use of iSGLT2 in the treatment of patients with type 2 diabetes mellitus
    Garnica-Cuellar, Juan C.
    Lavalle-Gonzalez, Fernando J.
    Magana-Serrano, Jose A.
    Almeda-Valdes, Paloma
    Canto, Jose A. Cetina
    Iniguez, J. S. Chavez
    Garcia, Carlos A. Garza
    Gonzalez-Chavez, Antonio
    Gonzalez-Galvez, Guillermo
    Medina-Chavez, Juan H.
    Morales, Gela Pimentel
    Sanchez-Pedraza, Valentin
    GACETA MEDICA DE MEXICO, 2022, 158 : 1 - 14
  • [38] Effect of statin treatment on mortality in elderly patients with type 2 diabetes mellitus patients: a retrospective cohort study
    Fan, Yao
    Wang, Juan
    Wu, Haidi
    Dai, Lingli
    Wang, Lan
    Gu, Liubao
    BMC GERIATRICS, 2023, 23 (01)
  • [39] Advances in the treatment of type 2 diabetes: impact of dulaglutide
    Thompson, Angela M.
    Trujillo, Jennifer M.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2016, 9 : 125 - 136
  • [40] Linagliptin for the treatment of type 2 diabetes mellitus: a drug safety evaluation
    Barnett, Anthony H.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (01) : 149 - 159
12345